Stay updated with breaking news from Allon Klein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Somite Therapeutics, a tech-bio company harnessing big data and AI to pioneer novel cell replacement therapies, is thrilled to announce the...
Jensen Huang: "For the very first time in human history, biology has the opportunity to be engineering, not science."
Somite.ai aims to improve the lives of millions of people by leveraging AI to produce human tissue for cell therapies.
Neutrophils, the blood cell types are mobilized to fight cancer if they are appropriately engaged.
Two independent Ludwig Cancer Research studies published in the current issue of the journal Cell show that immune cells known as neutrophils, whose abundance in the microenvironment of tumors has traditionally been associated with poor patient prognosis, can play an important role in the success of cancer immunotherapies.